Landscapes / Companies
Sarepta Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
5
in active trials · 13 in all
Trials
5 active
20 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Delandistrogene moxeparvovecnot checked |
Gene therapy substances |
Approved | 31 Aug 2027Phase 4 trial completes | ||
| How it works | A gene therapy | ||||
| Next date | 31 Aug 2027 · Phase 4 trial completes | ||||
| Also tested for | Duchenne Muscular Dystrophy | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Limb-girdle Muscular Dystrophy | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2026Phase 1/2 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Myotonic Dystrophy 1 | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2028Phase 1/2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Muscular Dystrophy, Facioscapulohumeral | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2027Phase 1 trial completes | |||
| Next date | 30 Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Huntington's Disease | ||||
| Open drug page | |||||
About
- No active trial
- 8 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021